Determining the correct retatrutide amount is vitally important for achieving optimal benefits. Initially, people typically begin with a low quantity of approximately 2.4 mg, given each week via subcutaneous . This preliminary amount is then incrementally raised every four weeks , reaching a maximum quantity of 10.8 mg, based on patient response a